Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ)

CNY 6.11

(-0.49%)

Market Cap (In CNY)

4.99 Billion

Revenue (In CNY)

1.04 Billion

Net Income (In CNY)

-24.92 Million

Avg. Volume

8.01 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.43-7.17
PE
-
EPS
-
Beta Value
0.108
ISIN
CNE000001QR4
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Zhiwei Shen
Employee Count
-
Website
https://www.bohui-tech.com
Ipo Date
2012-05-23
Details
Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. It offers GenPlex, a microfluidic automated nucleic acid detection system, immunofluorescence detection products, and human trace element detection products; and chemical analysis products, such as atomic fluorescence spectrometer and photometer, mass spectrometers, chip ion sources, microfluidic flow chemical analysis systems, life sciences related consumables, and ICP spectroscopy. The company was formerly known as Beijing Bohui Innovation Biotechnology Co., Ltd. and changed its name to Beijing Bohui Innovation Biotechnology Group Co., Ltd. in August 2021. Beijing Bohui Innovation Biotechnology Group Co., Ltd. was founded in 2001 and is headquartered in Beijing, China.